RecallDepth
Class III Terminated

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.

This recall has been terminated (originally issued November 20, 2024).

Company
The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories
Recall Initiated
November 5, 2024
Posted
November 20, 2024
Recall Number
D-0045-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
25814 tablets
Firm Location
La Vergne, TN, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications; during routine stability testing for impurities.

Distribution

Nationwide in the US.

Lot / Code Info

Lot#: T04888, Exp 11/2024; T04946, Exp 12/2024; T04970, Exp 07/2025

More recalls by The Harvard Drug Group Llc Dba Major Pharmaceuticals And Rugby Laboratories

View all recalls by this company →

Other recent Class III Drug recalls